STOXPO
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
STOXPO
No Result
View All Result
Home Healthcare Biotechnology
chemistry

Rallybio Collaborates with Johnson & Johnson to Tackle Rare Disease FNAIT

byLiliana Vida
April 11, 2024
in Biotechnology, Small-Cap
Reading Time: 1 min read
Share on TwitterShare on LinkedIn

Partnership Aims to Develop Therapeutic Solutions for Fetal and Neonatal Alloimmune Thrombocytopenia

Rallybio Corporation (RLYB) has announced a collaboration with Johnson & Johnson to advance therapeutic approaches for reducing the risk of fetal and neonatal alloimmune thrombocytopenia (FNAIT). This collaboration includes a $6.6 million equity investment from Johnson & Johnson Innovation – JJDC, Inc.

Rallybio’s focus lies in developing RLYB212, a human monoclonal anti-HPA-1a antibody designed to prevent pregnant individuals from alloimmunizing, thereby mitigating the risk of FNAIT in fetuses and newborns. With plans to initiate a Phase 2 dose confirmation study for RLYB212 in the second half of 2024, Rallybio aims to address the critical need for preventative treatment options in individuals at higher risk of FNAIT.

The collaboration with Johnson & Johnson involves funding to raise awareness of Johnson & Johnson’s FNAIT clinical program alongside Rallybio’s ongoing natural history study. Together, the companies aspire to drive awareness, screening, and therapeutic advancements to combat FNAIT, ultimately improving outcomes for affected individuals.

Read original press release:here

You might like this article:Vertex Pharmaceuticals to Acquire Alpine Immune Sciences in $4.9 Billion Deal

Previous Post

Vertex Pharmaceuticals to Acquire Alpine Immune Sciences in $4.9 Billion Deal

Next Post

Candel Therapeutics’ CAN-2409 Receives FDA Orphan Drug Designation for Pancreatic Cancer

Related Posts

ProMIS Neurosciences Soars 160% After FDA Fast Track Designation for Alzheimer’s Drug

byLiliana Vida
July 21, 2025
0

PMN310 aims to deliver a safer, next-generation treatment by targeting toxic amyloid-beta in early-stage Alzheimer’s patients Shares of ProMIS Neurosciences...

Regencell Bioscience’s Stock Whipsaws Again Amid 17,000% Surge in 2025

byLuca Blaumann
July 7, 2025
0

Following a 38-to-1 stock split and explosive rally, the biotech firm's volatile trading persists despite a multi-year loss streak Regencell...

trading-chart-2

BitMine Raises $250 Million to Launch One of the Largest Public Ether Treasuries

byLuca Blaumann
June 30, 2025
0

Ethereum-focused strategy attracts top crypto investors as BitMine stock surges on bold treasury pivot BitMine Immersion Technologies (BMNR) has announced...

Next Post
chemistry-2

Candel Therapeutics' CAN-2409 Receives FDA Orphan Drug Designation for Pancreatic Cancer

Latest News

Qualcomm Posts Strong Q3 Results, Fueled by Automotive and IoT Growth

Palo Alto Networks Eyes $20B Deal for CyberArk

AMD and Amazon: Two Titans Poised for Explosive Growth

FCC Approves $8B Paramount-Skydance Merger Amid Political Controversy

FAA Keeps Boeing 737 MAX Production Cap in Place Amid Ongoing Oversight

Based on Your Interest

Large-Cap

Intel Beats on Revenue, Misses on Earnings; Cuts Workforce by 15%

July 24, 2025
trading-chart-2
Brokerages

Accelerant Soars in NYSE Debut, Valued at $6.4 Billion

July 24, 2025
investing
Distributor

GoPro and Krispy Kreme Surge as Meme Stock Frenzy Reignites

July 23, 2025

Recommended

Electrical Equipment

GE Vernova Soars to Record High on Raised Cash Flow Outlook

July 23, 2025
Auto Manufacturers

Earnings Season Surprises: Coca-Cola Delivers, GM Struggles Under Tariff Pressure

July 22, 2025
Entertainment

Trump Media Stock Rises After $2 Billion Bitcoin Bet

July 21, 2025
Biotechnology

ProMIS Neurosciences Soars 160% After FDA Fast Track Designation for Alzheimer’s Drug

July 21, 2025
Bitcoin

Michael Saylor’s Strategy Now Holds Over 3% of All Bitcoin Ever Minted

July 21, 2025
Stoxpo

Follow us on social media:

Highlights

  • Qualcomm Posts Strong Q3 Results, Fueled by Automotive and IoT Growth
  • Palo Alto Networks Eyes $20B Deal for CyberArk
  • AMD and Amazon: Two Titans Poised for Explosive Growth
  • FCC Approves $8B Paramount-Skydance Merger Amid Political Controversy
  • FAA Keeps Boeing 737 MAX Production Cap in Place Amid Ongoing Oversight

Category

  • Blog
  • Communication Services
    • Entertainment
    • Internet
    • Telecommunications
  • Companies
    • Large-Cap
    • Mega-Cap
    • Micro-Cap
    • Mid-Cap
    • Small-Cap
  • Consumer Cyclical
    • Auto Manufacturers
    • Casinos & Gambling
    • Ground Transportation
    • Hospitality
      • Casinp
      • Resorts & Lodging
      • Restaurants
      • Travel
        • Airlines
    • Retail
    • Textiles, Apparel & Luxury Goods
  • Consumer Defensive
    • Beverages
    • Discount Stores
    • Distributor
    • Ecommerece
    • Electrical Equipment
    • Foods
    • Household & Personal Products
    • Leisure Products
    • Tobacco
  • Contributions
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Economy
  • Energy
    • Electric
    • Oil & Gas
    • Renewables
  • Financial Services
    • Asset Management
    • Banks
    • Brokerages
    • Credit Services
    • Insurance
  • Healthcare
    • Biotechnology
    • Medical Devices
    • Pharmaceuticals
  • Industrials
    • Aerospace & Defense
    • Construction
    • Industrial Machinery
  • Materials
    • Building Materials
    • Chemicals
    • Gold
    • Mining
    • Silver
    • Steel
  • Q&A's
  • Real Estate
  • Technology
    • Artificial Intelligence
    • Computer Hardware
    • Consumer Electronics
    • Cybersecurity
    • IT Services
    • Semiconductors
    • Software
  • Utilities

Latest News

trading-chart-2

Qualcomm Posts Strong Q3 Results, Fueled by Automotive and IoT Growth

July 30, 2025

Palo Alto Networks Eyes $20B Deal for CyberArk

July 29, 2025
trading-chart

AMD and Amazon: Two Titans Poised for Explosive Growth

July 28, 2025
  • About
  • Privacy Policy
  • Contact

© 2024 All Rights Reserved: STOXPO.

No Result
View All Result
  • Latest News
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Technology
    • Software
    • Semiconductors
  • Crypto
    • Bitcoin
    • Ethereum
    • Altcoins
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions

© 2024 All Rights Reserved: STOXPO.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More

In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information

Accept Cookie Settings
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
  • Always Active
    Necessary
    Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
  • Marketing
    Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
  • Analytics
    Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
  • Preferences
    Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
  • Unclassified
    Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
Cookie Settings

Do you really wish to opt-out?